Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

NCT01520753 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 70
DRUG: biphasic insulin aspart 70
DRUG: biphasic insulin aspart 50

Sponsor

Novo Nordisk A/S